Immunohistochemical expression HIF1α in chronic plaque psoriasis, an association with angiogenesis and proliferation

References

• Griffiths, C. E.; Walt, J. M.; Ashcroft, D. M.; Flohr, C.; Naldi, L.; Nijsten, T.; Augustin, M. The Global State of Psoriasis Disease Epidemiology: A Workshop Report. Br. J. Dermatol.2017, 177(1), e4–e7. DOI: 10.1111/bjd.15610.
   PubMed Web of Science ®Google Scholar
• Mansouri, Y.; Goldenberg, G. Biologic Safety in Psoriasis: Review of Long-Term Safety Data. J. Clin. Aesthet. Dermatol.2015, 8(2), 30–42.
   PubMedGoogle Scholar
• Wang, X.; Ren, J.; Li, J.; An, J.; Liu, W. Expression and Correlation of HIF-1α, MIF, COX-2 and VEGF in Psoriasis Lesions. Biomed. Res.2016, 27(3), 676–681.
   Google Scholar
• Melvin, A.; Rocha, S. Chromatin as an Oxygen Sensor and Active Player in the Hypoxia Response Cell. Signal.2012, 24, 35–43. DOI: 10.1016/j.cellsig.2011.08.019.
   PubMed Web of Science ®Google Scholar
• Palazon, A.; Goldrath, A.; Nizet, V.; Johnson, R. HIF Transcription Factors, Inflammation, and Immunity. Immunity.2014, 41(4), 518–528. DOI: 10.1016/j.immuni.2014.09.008.
   PubMed Web of Science ®Google Scholar
• Liu, X.;. Q6, a Novel Hypoxia-Targeted Drug, Regulates Hypoxia-Inducible Factor Signaling via an Autophagy-Dependent Mechanism in Hepatocellular Carcinoma. Autophagy.2014, 10, 111–122. DOI: 10.4161/auto.26838.
   PubMed Web of Science ®Google Scholar
• Icen, M.; Crowson, C. S.; McEvoy, M. T.; Dann, F. J.; Gabriel, S. E.; MaraditKremers, H. Trends in Incidence of Adult-Onset Psoriasis over Three Decades: A Population-Based Study. J. Am. Acad. Dermatol.2009, 60(3), 394–401. DOI: 10.1016/j.jaad.2008.10.062.
   PubMed Web of Science ®Google Scholar
• Sidney, L. E. 1.; Branch, M. J.; Dunphy, S. E.; Dua, H. S.; Hopkinson, A. Concise Review: Evidence for CD34 as a Common Marker for Diverse Progenitors. Stem Cells.2014, 32(6), 1380–1389. DOI: 10.1002/stem.1661.
   PubMed Web of Science ®Google Scholar
• Scholzen, T.; Gerdes, J. The Ki-67 Protein: From the Known and the Unknown. J. Cell. Physiol.2000, 182(3), 311–322. DOI: 10.1002/(ISSN)1097-4652.
   PubMed Web of Science ®Google Scholar
• Bruno, S.; Darzynkiewicz, Z. Cell Cycle Dependent Expression and Stability of the Nuclear Protein Detected by Ki-67 Antibody in HL-60 Cells. Cell Prolif.1992, 25(1), 31–40. DOI: 10.1111/j.1365-2184.1992.tb01435.x.
   PubMed Web of Science ®Google Scholar
• Arzynkiewicz, Z.; Zhao, H.; Zhang, S.; Lee, M. Y.; Lee, E. Y.; Zhang, Z. Initiation and Termination of DNA Replication during S Phase in Relation to Cyclins D1, E and A, p21WAF1, Cdt1 and the P12 Subunit of DNA Polymerase δ Revealed in Individual Cells by Cytometry. Oncotarget.2015, 6(14), 11735–11750.
   PubMedGoogle Scholar
• Louden, B. A.; Pearce, D. J.; Lang, W.; Feldman, S. R.; Simplified Psoriasis, A. Area Severity Index (SPASI) for Rating Psoriasis Severity in Clinic Patients. Dermatol. Online J.2004, 10(2), 7.
   PubMedGoogle Scholar
• Simonetti, O.; Lucarini, G.; Goteri, G.; Zizzi, A.; Biagini, G.; Lo Muzio, L.; Offidani, A. VEGF is likely a Key Factor in the Link between Inflammation and Angiogenesis in Psoriasis: Results of an Immunohistochemical Study. Int. J. Immunopathol. Pharmacol.2006, 19(4), 751–760. DOI: 10.1177/039463200601900405.
   PubMed Web of Science ®Google Scholar
• Chawla, N.; Kataria, S. P.; Aggarwal, K.; Chauhan, P.; Kumar, D. Significance of VEGF and CD31 and Morphometric Analysis of Microvessel Density by CD31 Receptor Expression as Adjuvant Tool in Diagnosis of Psoriatic Lesion of Skin. Indian J. Pathol. Microbiol.2017, 60(2), 189. DOI: 10.4103/IJPM.IJPM_862_15.
   PubMed Web of Science ®Google Scholar
• Rosenberger, C.; Solovan, C.; Rosenberger, A. D.; Jinping, L.; Treudler, R.; Frei, U.; Eckardt, K. U.; Brown, L. F. Upregulation of Hypoxia-Inducible Factors in Normal and Psoriatic Skin. J. Invest. Dermatol.2007, 127(10), 2445–2452. DOI: 10.1038/sj.jid.5700874.
   PubMed Web of Science ®Google Scholar
• Tao, J.; Yang, J.; Wang, L.; Li, Y.; Liu, Y. Q.; Dong, J.; Li, L.; Wen, X.; Shen, G. X.; Tu, Y. T. Expression of GLUT-1 in Psoriasis and the Relationship between GLUT-1 Upregulation Induced by Hypoxia and Proliferation of Keratinocyte Growth. J. Dermatol. Sci.2008, 51(3), 203–207. DOI: 10.1016/j.jdermsci.2008.04.012.
   PubMed Web of Science ®Google Scholar
• Amer, A. W.; Fahmy, S. F.; Faheem, M. A.; Ibrahim, O. A. Hypoxia Inducible Factor-1 Alpha in Psoriatic Patients. Aamj.2012, 10(3), 2.
   Google Scholar
• Li, Y.; Su, J.; Li, F.; Chen, X.; Zhang, G. MiR-150 Regulates Human Keratinocyte Proliferation in Hypoxic Conditions through Targeting HIF-1α and VEGFA: Implications for Psoriasis Treatment. PloS One.2017, 12(4), e0175459. DOI: 10.1371/journal.pone.0175459.
   PubMed Web of Science ®Google Scholar
• Ioannou, M.; Sourli, F.; Mylonis, I.; Barbanis, S.; Papamichali, R.; Kouvaras, E.; Zafiriou, E.; Siomou, P.; Klimi, E.; Simos, G.; Roussaki‐Schulze, A. V. Increased HIF‐1 Alpha Immunostaining in Psoriasis Compared to Psoriasiform Dermatitides. J. Cutan. Pathol.2009, 36(12), 1255–1256. DOI: 10.1111/j.1600-0560.2009.01264.x.
   PubMed Web of Science ®Google Scholar
• Vasilopoulos, Y.; Sourli, F.; Zafiriou, E.; Klimi, E.; Ioannou, M.; Mamuris, Z.; Simos, G.; Koukoulis, G.; Roussaki-Schulze, A. High Serum Levels of HIF1α Correlate with Overexpression of O IL-6. Cytokine.2013, 62(1), 38–39. DOI: 10.1016/j.cyto.2013.02.029.
   PubMed Web of Science ®Google Scholar
• Demidenko, Z. N.; Blagosklonny, M. V. The Purpose of the HIF-1/PHD Feedback Loop: To Limit mTOR-induced HIF-1α. Cell Cycle.2011, 10(10), 1557–1562. DOI: 10.4161/cc.10.10.15789.
   PubMed Web of Science ®Google Scholar
• Li, Y.; Zhang, G.; Xiao, R.; Chen, H.; Wen, H. Expression of iNOS and HIF-1α with Angiogenesis in Affected Skin Biopsies from Patients with Psoriasis. Zhong Nan Da Xue Xue Bao Yi Xue Ban.2010, 35(9), 952–957.
   PubMedGoogle Scholar
• Sun, J.; Tao, S.; Liu, L.; Guo, D.; Xia, Z.; Huang, M. miR-140-5p Regulates Angiogenesis following Ischemic Stroke by Targeting VEGFA. Mol. Med. Rep.2016, 13(5), 4499–4505. DOI: 10.3892/mmr.2016.5066.
   PubMed Web of Science ®Google Scholar
• Wu, Z.; Cai, X.; Huang, C.; Xu, J.; Liu, A. miR-497 Suppresses Angiogenesis in Breast Carcinoma by Targeting HIF-1α. Oncol. Rep.2016, 35(3), 1696–1702. DOI: 10.3892/or.2015.4529.
   PubMed Web of Science ®Google Scholar